ClinicalTrials.gg
Drug

Iptacopan clinical trials

Also written LNP023.

studies test it
27
open now
11
in phase 3
15
first study started
2018

How each study uses iptacopan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the iptacopan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 Dec 2023 · FABHALTA · NDA 218276 (FDA, Drugs@FDA)
European Union
17 May 2024 · Fabhalta · EMEA/H/C/005764 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Iptacopan
22
Iptacopan (LNP023)
2

Development codes

LNP023
20

Studies by the year they started

27 studies that test it; most in 2021 (8)

Studies that test iptacopan, by start year
YearStudies
20182
20194
20218
20222
20232
20244
20254
20261

Who runs them

Industry 25 · Other 2

Novartis Pharmaceuticals (25) · Bing Han (1) · First Affiliated Hospital of Zhejiang University (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 3 in phase 3

Studies that test iptacopan, phase 3 first.

Studies

Open first, then newest update. How each study uses iptacopan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 27

See all 27 studies that test iptacopan →

Given beside what is tested · 1 — iptacopan is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with iptacopan

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call iptacopan · ClinicalTrials.gg INT002086

  • MeSH (NLM) C000730766iptacopanConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 8E05T07Z6WIPTACOPANConfirmed FDA, NLM, Wikidata
  • Wikidata Q76803684iptacopanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C156691IptacopanOne source FDA
  • DrugBank DB16200One source Wikidata

Also registered as iptacopan hydrochloride (UNII XW5CK7C6YH).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.